Plus, initial jobless claims again came in above 1 million, Johnson & Johnson is launching a trial for its coronavirus vaccine candidate with 60,000 people next month, and Airbnb filed to go public.
Read MorePlus, there’s fresh hope on the stimulus front, Target delivered a blowout earnings report, and Johnson & Johnson is buying Momenta Pharmaceuticals.
Read MoreSome of the early-morning market commentary today focused on the fact that with yesterday’s close, the S&P 500 has moved above its pre-pandemic high – leading those participating to call for the “official” end to the shortest bear market in history. While that may technically be true, it doesn’t automatically mean that investors should take […]
Read MorePlus, Senate Republicans are planning to introduce a scaled back stimulus bill as the standoff with Democrats over a new virus relief plan continues, Quest Diagnostics sped up its coronavirus testing turnaround time, and three big retailers reported earnings.
Read MorePlus, the FDA granted Yale University’s saliva-based coronavirus test emergency use authorization, Sanofi is buying Principia Biopharma, and Amazon is mulling an investment in Rackspace Technologies.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreBuy Price: $2.25 or better Sell Price: TradersPro Sell Signal PAVmed Inc. operates as a medical device company in the United States. The company’s lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous […]
Read MorePlus, It just got even more unlikely Congress will come to agreement on the next coronavirus relief bill before September, Novavax reached a deal with the U.K. for 60 million doses of its coronavirus vaccine, and Simon Property Group is teaming up with Authentic Brands Group to take over Lucky Brand.
Read MoreTrade Setup Buy Target: $22.94 Sell Target: $26.07 Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is developing small molecule drug candidates primarily engineered to increase muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac […]
Read MoreBuy Price: $8.00 or better Sell Price: TradersPro Sell Signal Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and completed […]
Read MorePlus, Novavax signed a deal with SK Bioscience to manufacture the antigen component of its COVID-19 vaccine candidate, Apple is reportedly preparing bundles of its digital services, and Tapestry shares are down after reporting earnings.
Read MorePlus, China wants TikTok and WeChat to be on the agenda in upcoming trade talks with the U.S., the U.S. government will purchase at least 100 million doses of Moderna’s coronavirus vaccine, and Stein Mart just became the latest retailer to declare bankruptcy.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MorePlus, Treasury Secretary Mnuchin said the Trump administration is open to resuming talks with Democratic leaders on a new coronavirus relief bill as cases in the U.S. surpass 5 million, and Amazon is in discussions to take over old JCPenney and Sears stores to convert them into Amazon fulfillment centers.
Read MorePlus, President Trump issued an executive order banning TikTok and WeChat, July job gains came in just under 1.8 million, and coronavirus relief bill talks have stalled.
Read More